MedCity News October 6, 2025
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions.
Tariffs are the latest disruption facing medtech companies, but they won’t be the last. Protectionism, extreme weather events, geopolitical tensions, and regulatory shifts will keep coming and expose companies to ever-evolving risks. Some medtech companies have started putting measures in place to reduce tariffs and comply with new trade requirements. But they shouldn’t stop there.
Tomorrow’s winners in medtech will be those that look beyond trade compliance and build resilience muscles along the supply chain...
Today's Sponsors
Today's Sponsor